Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
MRX-8 by MicuRx Pharmaceuticals for Pseudomonas aeruginosa Infections: Likelihood of Approval
MRX-8 is under clinical development by MicuRx Pharmaceuticals and currently in Phase I for Pseudomonas aeruginosa Infections. According to GlobalData,...
MRX-8 by MicuRx Pharmaceuticals for Escherichia coli Infections: Likelihood of Approval
MRX-8 is under clinical development by MicuRx Pharmaceuticals and currently in Phase I for Escherichia coli Infections. According to GlobalData,...
MRX-8 by MicuRx Pharmaceuticals for Acinetobacter Infections: Likelihood of Approval
MRX-8 is under clinical development by MicuRx Pharmaceuticals and currently in Phase I for Acinetobacter Infections. According to GlobalData, Phase...
Contezolid by MicuRx Pharmaceuticals for Diabetic Foot Infection (DFI): Likelihood of Approval
Contezolid is under clinical development by MicuRx Pharmaceuticals and currently in Phase III for Diabetic Foot Infection (DFI). According to...